PMGC Holdings Inc. SEC filings ELAB
PMGC Holdings Inc. has 273 filings in SEC EDGAR's recent list, going back to Oct 1, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 2, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2026 | Sep 18, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 2, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Aug 27, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 9, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
May 13, 2026 | May 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2026 | Apr 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 17, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2026 | Apr 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 23, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 10, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 3, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 10, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Feb 6, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 20, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 12, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Oct 30, 2025 | Oct 26, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 21, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 29, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 17, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 4, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 25, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 18, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 31, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Jul 22, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Jul 11, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 16, 2025 | May 12, 2025 |
| 8-K |
Current report
Material agreement
|
May 13, 2025 | May 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Other events
|
Apr 10, 2025 | Apr 9, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Apr 8, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 7, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results, Other events
|
Mar 27, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 21, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Mar 11, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 6, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Agreement ended
|
Mar 3, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 27, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 7, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Jan 17, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Other events
|
Jan 16, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Jan 14, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 7, 2025 | Dec 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 31, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Dec 30, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 23, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Change to shareholder rights, Other events
|
Nov 27, 2024 | Nov 27, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 26, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 26, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 22, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 31, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 25, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Other events
|
Oct 3, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 25, 2024 | Sep 22, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 6, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2024 | Jun 29, 2024 |
| 8-K |
Current report
Other events
|
Aug 26, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 2, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 12, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jun 26, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 20, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Listing notice
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Material agreement
|
May 9, 2024 | May 3, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
May 2, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Mar 7, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2024 | Jan 16, 2024 |
| 8-K/A | Amended current report | Dec 5, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 4, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 24, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 21, 2023 | Nov 20, 2023 |
Showing 102 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newport Beach, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840563
- Former names
- Elevai Labs Inc. (until Nov 27, 2024); Reactive Medical Labs Inc. (until Oct 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.